Yingyi Wang

7.1k total citations
169 papers, 5.0k citations indexed

About

Yingyi Wang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yingyi Wang has authored 169 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Molecular Biology, 55 papers in Cancer Research and 38 papers in Oncology. Recurrent topics in Yingyi Wang's work include MicroRNA in disease regulation (36 papers), Cancer-related molecular mechanisms research (34 papers) and Circular RNAs in diseases (28 papers). Yingyi Wang is often cited by papers focused on MicroRNA in disease regulation (36 papers), Cancer-related molecular mechanisms research (34 papers) and Circular RNAs in diseases (28 papers). Yingyi Wang collaborates with scholars based in China, United States and Hong Kong. Yingyi Wang's co-authors include Yongping You, Junxia Zhang, Ning Liu, Xiaoming Yang, Tianfu Yu, Xiefeng Wang, Tongle Zhi, Hong Miao, Weining Wu and Chunsheng Kang and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yingyi Wang

160 papers receiving 5.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingyi Wang China 40 3.0k 2.4k 567 494 292 169 5.0k
Ya Zhang China 35 3.0k 1.0× 1.8k 0.8× 1.4k 2.5× 180 0.4× 599 2.1× 184 5.7k
Yanjie Lu China 46 4.9k 1.7× 3.3k 1.4× 368 0.6× 252 0.5× 383 1.3× 133 7.5k
Song Li China 36 2.4k 0.8× 1.0k 0.4× 957 1.7× 169 0.3× 369 1.3× 177 5.2k
Jiaxing Wang China 42 2.6k 0.9× 859 0.4× 770 1.4× 571 1.2× 372 1.3× 164 5.7k
Fang Wang China 41 3.3k 1.1× 1.7k 0.7× 435 0.8× 115 0.2× 332 1.1× 313 6.2k
Shih‐Wei Wang Taiwan 40 2.2k 0.7× 935 0.4× 903 1.6× 244 0.5× 353 1.2× 201 4.9k
Ping Gu China 34 1.5k 0.5× 688 0.3× 472 0.8× 335 0.7× 490 1.7× 140 4.0k
Bin Lü China 50 5.9k 2.0× 891 0.4× 531 0.9× 198 0.4× 293 1.0× 203 8.2k
Bin Yu China 43 2.3k 0.8× 1.1k 0.5× 405 0.7× 150 0.3× 183 0.6× 167 5.2k
Fei Xing China 34 2.2k 0.7× 1.4k 0.6× 1.5k 2.6× 154 0.3× 906 3.1× 170 4.8k

Countries citing papers authored by Yingyi Wang

Since Specialization
Citations

This map shows the geographic impact of Yingyi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingyi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingyi Wang more than expected).

Fields of papers citing papers by Yingyi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingyi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingyi Wang. The network helps show where Yingyi Wang may publish in the future.

Co-authorship network of co-authors of Yingyi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yingyi Wang. A scholar is included among the top collaborators of Yingyi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingyi Wang. Yingyi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Hui, et al.. (2025). Analytical study on the backfill grouting in mitigation of vibrations from a tunnel embedded in a half-space. Tunnelling and Underground Space Technology. 161. 106587–106587.
2.
Liu, Hanxiao, Zhongjie Tang, Xu Li, et al.. (2025). Synergistic Amino and Hydroxyl Groups That Enhance SOD-Like Activity in Curcumin Carbon Dots for Improved Colitis Treatment. ACS Applied Materials & Interfaces. 17(34). 48075–48093.
4.
Wang, Yingyi, et al.. (2024). Induced expression of AMOT reverses adriamycin resistance in breast cancer cells. Cell Biology International. 48(9). 1301–1312. 1 indexed citations
5.
Li, Bingyan, Pengcheng Zhou, Huizhen Li, et al.. (2024). Analysis of the clinical efficacy and safety of anti‐PD‐1 immune checkpoint inhibitors in locally advanced nasopharyngeal cancer. Cancer Medicine. 13(14). e7359–e7359.
6.
Li, Qing, Chong Cui, Daqi Wang, et al.. (2023). The pathogenesis of common Gjb2 mutations associated with human hereditary deafness in mice. Cellular and Molecular Life Sciences. 80(6). 148–148. 9 indexed citations
8.
Liu, Yuanyuan, Qing Li, Hao Chen, et al.. (2023). Adenine base editor–mediated splicing remodeling activates noncanonical splice sites. Journal of Biological Chemistry. 299(12). 105442–105442. 5 indexed citations
9.
Liao, Yang, Yingyi Wang, Qing‐Qing Tao, et al.. (2023). CALHM2 V136G polymorphism reduces astrocytic ATP release and is associated with depressive symptoms and Alzheimer's disease risk. Alzheimer s & Dementia. 19(10). 4407–4420. 17 indexed citations
10.
Jin, Bao, Haifeng Xu, Xin Lü, et al.. (2023). Immune checkpoint inhibitor‐related molecular markers predict prognosis in extrahepatic cholangiocarcinoma. Cancer Medicine. 12(20). 20470–20481. 2 indexed citations
11.
Li, Yue, Yingyi Wang, Zuoping Xiong, et al.. (2022). Multifunctional biomimetic tactile system via a stick-slip sensing strategy for human–machine interactions. npj Flexible Electronics. 6(1). 62 indexed citations
12.
Gu, Junjie, Fan Bai, Lan Song, & Yingyi Wang. (2021). [Osimertinib Re-challenge for EGFR-mutant NSCLC after 
Osimertinib-induced Interstitial Lung Disease: A Case Report].. SHILAP Revista de lepidopterología. 24(11). 804–807. 2 indexed citations
13.
Li, Tiancheng, et al.. (2020). Antioncogenic Effect of MicroRNA-206 on Neck Squamous Cell Carcinoma Through Inhibition of Proliferation and Promotion of Apoptosis and Autophagy. Human Gene Therapy. 31(23-24). 1260–1273. 5 indexed citations
14.
Liu, Weixiao, Zaiyi Liu, Chunling Liu, et al.. (2020). Preoperative Prediction of Ki-67 Status in Breast Cancer with Multiparametric MRI Using Transfer Learning. Academic Radiology. 28(2). e44–e53. 41 indexed citations
15.
Hao, Yuting, Xiangdong Wang, Sijie Yuan, et al.. (2020). Flammulina velutipes polysaccharide improves C57BL/6 mice gut health through regulation of intestine microbial metabolic activity. International Journal of Biological Macromolecules. 167. 1308–1318. 39 indexed citations
16.
Qian, Chunfa, Ping Li, Wei Yan, et al.. (2014). Downregulation of osteopontin enhances the sensitivity of glioma U251 cells to temozolomide and cisplatin by targeting the NF-κB/Bcl-2 pathway. Molecular Medicine Reports. 11(3). 1951–1955. 18 indexed citations
17.
Sun, Guan, Ying Cao, Lei Shi, et al.. (2013). Overexpressed miRNA-137 Inhibits Human Glioma Cells Growth by Targeting Rac1. Cancer Biotherapy and Radiopharmaceuticals. 28(4). 327–334. 38 indexed citations
18.
Zhou, Zhimin, Lihua Sun, Yingyi Wang, et al.. (2011). Bone Morphogenetic Protein 4 Inhibits Cell Proliferation and Induces Apoptosis in Glioma Stem Cells. Cancer Biotherapy and Radiopharmaceuticals. 26(1). 77–83. 27 indexed citations
19.
Wang, Yingyi, et al.. (2010). Pharmacological Functions of Chemicals in Rhizoma Anemarrhenae. Keji daobao. 28(12). 110–115. 2 indexed citations
20.
Wang, Yingyi. (2007). Intercultural Communication and Foreign Language Teaching.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026